Time spent in hospital after liver transplantation: Effects of primary liver disease and comorbidity

Table 2 Unadjusted transplant length of stay and length of stay in later admissions in the first two years after liver transplantation regarding primary liver disease and comorbidities

Variable	n (%)	Unadjusted TLOS			Unadjusted LLOS
		(d)	95%CI	P-value	(d)	95%CI	P-value
Overall average	3772	25	24-26	N/A	24	23-26	N/A
Primary liver disease groups
Cancer	525 (13.9)	22	20-24	< 0.001	22	18-25	< 0.001
Acute hepatic failure	455 (12.1)	33	32-35		26	22-30
Hepatitis C cirrhosis	392 (10.4)	27	25-29		26	22-30
Primary sclerosing cholangitis	354 (9.4)	23	20-25		27	23-31
Hepatitis B cirrhosis	98 (2.6)	22	18-26		21	13-29
Primary biliary cirrhosis	507 (13.4)	21	20-23		20	16-23
Alcoholic cirrhosis	753 (20.0)	24	23-26		22	19-25
Autoimmune and cryptogenic	348 (9.2)	22	20-24		23	18-27
Metabolic liver disease	107 (2.8)	26	22-30		29	21-37
Other liver disease	233 (6.2)	28	26-31		37	32-42
Comorbidities
Cardiovascular disease	200 (5.3)	33	28-39	< 0.001	31	24-38	0.02
Congestive cardiac failure	82 (2.2)	32	24-39	0.003	18	13-24	0.18
Connective tissue disease	134 (3.6)	22	20-25	0.13	25	18-32	0.91
Dementia	159 (4.2)	25	21-28	0.87	26	21-32	0.54
Diabetes mellitus	784 (20.8)	24	23-26	0.42	26	23-29	0.18
Non-hepatic malignancy	40 (1.1)	23	17-29	0.65	24	10-37	0.91
Chronic pulmonary disease	344 (9.1)	27	25-30	0.04	28	24-33	0.06
Chronic renal disease	247 (6.6)	27	23-30	0.17	32	25-38	0.003

TLOS: Transplant length of stay; LLOS: Later length of stay; N/A: Not applicable.